SpineGuard develops disposable medical devices built around its proprietary DSG (Dynamic Surgical Guidance) technology to improve safety and accuracy in spine surgery. Its primary product, PediGuard, is described as the world’s first handheld device that alerts surgeons to potential pedicular or vertebral breaches, and has been used in over 40,000 surgical procedures worldwide. The company is expanding DSG applications into pedicle screws through partnerships with surgical companies in France and the U.S. and is preparing product launches including PediGuard Threaded and DSG "smart screws." SpineGuard was co‑founded in 2009 and maintains offices in San Francisco and Paris. Management cites peer‑reviewed studies and industry partnerships as clinical validation supporting its commercial expansion. The company recently strengthened its financial position with debt financing to underpin sales momentum and accelerate new-product launches. SpineGuard develops and commercializes disposable devices based on its Dynamic Surgical Guidance (DSG™) technology to improve safety in spine surgery. Its first DSG product, PediGuard®, is a handheld device that warns surgeons of potential pedicular or vertebral breaches; over 38,000 procedures have been performed with PediGuard worldwide. The company is expanding DSG applications into pedicle screws and other surgeries and has pursued partnerships to support that expansion, including work begun in 2015. Management highlighted the market launch of the first “smart screws” using DSG technology. SpineGuard operates offices in San Francisco and Paris and was co‑founded in 2009. The company reported a fresh equity fundraising drive in the second quarter to support commercialization and platform expansion. SpineGuard develops the PediGuard platform, a handheld device that alerts surgeons to potential pedicular or vertebral breaches with real-time audio and visual signals. The company launched PediGuard Curv earlier in the year and is preparing a limited release of its Cannulated PediGuard, a “smart needle” aimed at minimally invasive spine surgery. It raised $6.2M to further extend the PediGuard platform. SpineGuard is based in San Francisco and Paris and was founded in 2009 by Pierre Jérôme and Stéphane Bette. The founders previously held executive roles at Medtronic Sofamor-Danek and SpineVision. The company plans to apply the new funding to product development and platform extension.

Total raised

$16M

Funding rounds

4

Latest round

Debt Financing

Latest activity

Jan 2016